Our systematic review showed that vitamin E has clinical utility in improving biochemical (ALT and AST levels) and histological abnormalities in NAFLD (hepatic steatosis and lobular inflammation). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.